Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Humira
Pharma
Amid promising launch of Humira biosim, Sandoz sees 6% growth
With Hyrimoz leading the way, sales of the company’s biosimilars reached $623 million in the first three months of this year.
Kevin Dunleavy
May 7, 2024 11:17am
AbbVie's Skyrizi continues booming growth trajectory
Apr 26, 2024 12:06pm
Boehringer charts layoffs due to poor Humira biosim sales
Apr 5, 2024 11:19am
AbbVie's Gonzalez collects $25.7M in his final full year as CEO
Mar 19, 2024 11:22am
Teva and Alvotech's Humira biosimilar finally snags FDA approval
Feb 23, 2024 9:00pm
After 11 years, AbbVie CEO Gonzalez set to retire on July 1
Feb 20, 2024 10:52am